Company News
Huahui Health Secures $20M HH160 Deal
• Huahui Health announced a global exclusive option, license and collaboration with BeOne Medicines for the trispecific oncology antibody HH160.
• BeOne will pay USD 20 million upfront, USD 100 millio
